Assessment of TREM2 rs75932628 variant’s association with Parkinson’s disease in a Greek population and Meta-analysis of current data

References

• Deng H, Wang P, Jankovic J. The genetics of Parkinson disease. Ageing Research Reviews. 2018;42:72–85.
   PubMed Web of Science ®Google Scholar
• Evangelou E, Maraganore DM, Annesi G, et al. Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson’s disease: large-scale collaborative study. Amer J Med Genet B, Neuropsychiatric Genet. 2010;153b 1:220–228.
   PubMed Web of Science ®Google Scholar
• Kalinderi K, Bostantjopoulou S, Fidani L. The genetic background of Parkinson’s disease: current progress and future prospects. Acta Neurol Scand. 2016;134(5):314–326.
   PubMed Web of Science ®Google Scholar
• Karimi-Moghadam A, Charsouei S, Bell B, et al. Parkinson disease from Mendelian forms to genetic susceptibility: new molecular insights into the neurodegeneration process. Cell Mol Neurobiol. 2018;38(6):1153–1178.
   PubMed Web of Science ®Google Scholar
• Fabbri M, Reimao S, Carvalho M, et al. Substantia Nigra neuromelanin as an imaging biomarker of disease progression in Parkinson’s disease. JPD. 2017;7(3):491–501.
   Web of Science ®Google Scholar
• Barnum CJ, Tansey MG. Modeling neuroinflammatory pathogenesis of Parkinson's disease. Prog Brain Res. 2010;184:113–132.
   PubMed Web of Science ®Google Scholar
• Lawson LJ, Perry VH, Dri P, et al. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39(1):151–170.
   PubMed Web of Science ®Google Scholar
• Kannarkat GT, Boss JM, Tansey MG. The Role of Innate and Adaptive Immunity in Parkinson’s. Dis J Parkinson’s Dis. 2013;3(4):493–514.
   PubMedGoogle Scholar
• Sanchez-Guajardo V, Barnum CJ, Tansey MG, et al. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. 2013;5(2):113–39.
   PubMed Web of Science ®Google Scholar
• Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3(6):445–453.
   PubMed Web of Science ®Google Scholar
• Hsieh CL, Koike M, Spusta SC, et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem. 2009;109(4):1144–1156.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Siokas V, Pantazi E, et al. Novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature. Neurobiol Ag. 2017;53:194.e13–194.e22.
   PubMed Web of Science ®Google Scholar
• Guerreiro R, Wojtas A, Bras J, et al. TREM2 variants in Alzheimer’s disease. N Engl J Med. 2013;368(2):117–127.
   PubMed Web of Science ®Google Scholar
• Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med. 2013;368(2):107–116.
   PubMed Web of Science ®Google Scholar
• Rayaprolu S, Mullen B, Baker M, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease. Mol Neurodegeneration. 2013;8(1):19.
   PubMed Web of Science ®Google Scholar
• Borroni B, Ferrari F, Galimberti D, et al. Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol Aging. 2014;35(4):934.e7–10.
   PubMed Web of Science ®Google Scholar
• Thelen M, Razquin C, Hernandez I, et al. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes. Neurobiol Ag. 2014;35(11):2657.e13–2657.e19.
   PubMed Web of Science ®Google Scholar
• Cady J, Koval ED, Benitez BA, et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol. 2014;71(4):449–453.
   PubMed Web of Science ®Google Scholar
• Ortega-Cubero S, Lorenzo-Betancor O, Lorenzo E, et al. TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study. Parkinsonism Related Disorders. 2015;21(3):306–309.
   PubMed Web of Science ®Google Scholar
• Benitez BA, United States–Spain Parkinson’s Disease Research Group, Cruchaga C. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369(16):1567–1568.
   PubMed Web of Science ®Google Scholar
• Jonsson T, Stefansson K. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369(16):1568–1569.
   PubMed Web of Science ®Google Scholar
• Feng SJ, Nie K, Gan R, et al. Triggering receptor expressed on myeloid cells 2 variants are rare in Parkinson’s disease in a Han Chinese cohort. Neurobiol Ag. 2014;35(7):1780.e11–2.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen X, Guo X, et al. Assessment of TREM2 rs75932628 association with Parkinson’s disease and multiple system atrophy in a Chinese population. Neurol Sci. 2015;36(10):1903–1906.
   PubMed Web of Science ®Google Scholar
• Lill CM, Rengmark A, Pihlstrom L, et al. The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimer’s Dement. 2015;11(12):1407–1416.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhong L, Gu L, et al. Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson’s disease in the Han Chinese population. BMJ Open. 2016;6(1):e009499.
   PubMed Web of Science ®Google Scholar
• Mengel D, Thelen M, Balzer-Geldsetzer M, et al. TREM2 rare variant p.R47H is not associated with Parkinson’s disease. Parkinsonism Related Disorders. 2016;23:109–111.
   PubMed Web of Science ®Google Scholar
• Tan T, Song Z, Yuan L, et al. Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson’s disease. Neurosci Lett. 2016;612:189–192.
   PubMed Web of Science ®Google Scholar
• Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol, Neurosurgery, Psychiatry. 2008;79(4):368–376.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Paterakis K, Siokas V, et al. Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury. Pharmacogenet Genomics. 2015;25(10):485–490.
   PubMed Web of Science ®Google Scholar
• R Development Core Team. R: A Language and Environment for Statistical Computing. 2016;55:275–286.http://www.R-project.org
   Google Scholar
• Schwarzer G, Carpenter JR, Rücker G. Meta-Analysis with R. 1 ed.: Springer International Publishing; 2015. https://www.springer.com/gp/book/9783319214153#reviews
   Google Scholar
• Dardiotis E, Xiromerisiou G, Hadjichristodoulou C, et al. The interplay between environmental and genetic factors in Parkinson’s disease susceptibility: the evidence for pesticides. Toxicology. 2013;307:17–23.
   PubMed Web of Science ®Google Scholar
• Li Y, Rowland C, Xiromerisiou G, et al. Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson’s disease. PloS One. 2008;3(7):e2707.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Tsouris Z, Mentis AA, et al. H. pylori and Parkinson’s disease: Meta-analyses including clinical severity. Clin Neurol Neurosurg. 2018;175:16–24.
   PubMed Web of Science ®Google Scholar
• Bellou V, Belbasis L, Tzoulaki I, et al. Environmental risk factors and Parkinson’s disease: An umbrella review of meta-analyses. Parkinsonism Relat Disord. 2016;23:1–9.
   PubMed Web of Science ®Google Scholar
• Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: The PDGene database. PLoS Genet. 2012;8(3):e1002548.
   PubMed Web of Science ®Google Scholar
• Kruger R, Sharma M, Riess O, et al. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson’s disease. Neurobiol Ag. 2011;32(3):548.e9–18.
   PubMed Web of Science ®Google Scholar
• Wang L, Aasly JO, Annesi G, et al. Large-scale assessment of polyglutamine repeat expansions in Parkinson disease. Neurology. 2015;85(15):1283–1292.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Siokas V, Sokratous M, et al. Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants. Environ Int. 2018;116:122–135.
   PubMed Web of Science ®Google Scholar